Ameriprise Financial Inc Evolus, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Evolus, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 72,232 shares of EOLS stock, worth $786,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,232

Previous 83,224 13.21%

Holding current value

$786,606

Previous $902,000 29.71%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.66 - $17.48 $117,174 - $192,140	-10,992 Reduced 13.21%	72,232 $1.17 Million
Q2 2024 Aug 14, 2024	SELL	$10.45 - $13.76 $106,245 - $139,897	-10,167 Reduced 10.89%	83,224 $902,000
Q1 2024 May 15, 2024	SELL	$9.99 - $14.91 $177,302 - $264,622	-17,748 Reduced 15.97%	93,391 $1.31 Million
Q4 2023 Feb 14, 2024	SELL	$7.6 - $10.53 $101,209 - $140,228	-13,317 Reduced 10.7%	111,139 $1.17 Million
Q3 2023 Nov 14, 2023	BUY	$7.15 - $10.2 $666,272 - $950,486	93,185 Added 297.99%	124,456 $1.14 Million
Q2 2023 Aug 14, 2023	BUY	$7.23 - $10.52 $2,458 - $3,576	340 Added 1.1%	31,271 $227,000
Q1 2023 May 15, 2023	SELL	$7.81 - $11.05 $10,153 - $14,365	-1,300 Reduced 4.03%	30,931 $261,000
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.95 $6,454 - $8,860	990 Added 3.17%	32,231 $242,000
Q3 2022 Nov 14, 2022	SELL	$7.76 - $13.72 $2,948 - $5,213	-380 Reduced 1.2%	31,241 $251,000
Q2 2022 Aug 15, 2022	SELL	$10.22 - $13.94 $11,139 - $15,194	-1,090 Reduced 3.33%	31,621 $367,000
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $3,758 - $8,481	720 Added 2.25%	32,711 $367,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $18,848 - $29,413	-3,510 Reduced 9.89%	31,991 $208,000
Q3 2021 Nov 15, 2021	SELL	$7.36 - $13.67 $12,681 - $23,553	-1,723 Reduced 4.63%	35,501 $271,000
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $28,207 - $46,766	3,350 Added 9.89%	37,224 $471,000
Q1 2021 May 17, 2021	SELL	$3.2 - $16.51 $960 - $4,953	-300 Reduced 0.88%	33,874 $440,000
Q4 2020 Feb 12, 2021	SELL	$2.92 - $4.84 $9,335 - $15,473	-3,197 Reduced 8.55%	34,174 $115,000
Q3 2020 Nov 16, 2020	SELL	$3.03 - $5.48 $7,665 - $13,864	-2,530 Reduced 6.34%	37,371 $146,000
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.17 $8,772 - $15,332	2,485 Added 6.64%	39,901 $211,000
Q1 2020 May 15, 2020	SELL	$3.53 - $12.21 $2,255 - $7,802	-639 Reduced 1.68%	37,416 $155,000
Q4 2019 Feb 14, 2020	SELL	$11.58 - $17.37 $33,894 - $50,841	-2,927 Reduced 7.14%	38,055 $463,000
Q3 2019 Nov 14, 2019	BUY	$13.91 - $19.87 $20,517 - $29,308	1,475 Added 3.73%	40,982 $640,000
Q2 2019 Aug 14, 2019	SELL	$13.19 - $28.36 $2,980 - $6,409	-226 Reduced 0.57%	39,507 $578,000
Q1 2019 May 15, 2019	BUY	$12.43 - $28.91 $493,881 - $1.15 Million	39,733 New	39,733 $897,000

Others Institutions Holding EOLS

# of Institutions

168

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $611M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Evolus, Inc. Transaction History